Search Our Site

News filed in:

"Latest News"

Huntington’s breakthrough may stop disease

The defect that causes the neurodegenerative disease Huntington’s has been corrected in patients for the first time, the BBC has learned. An experimental drug, injected into spinal fluid, safely lowered levels of toxic proteins in the brain. The research team, at University College London, say there is now hope the deadly disease can be stopped.... Read More »

Read More →

The defect that causes the neurodegenerative disease Huntington’s has been corrected in patients for the first time, the BBC has learned. An experimental drug, injected into spinal fluid, safely lowered levels of toxic proteins in the brain. The research team, at University College London, say there is now hope the deadly disease can be stopped…. Read More »

[...]

Read More

Experts Tell Congress How To Cut Drug Prices

The nation’s most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to change. “Drugs that are not affordable are of little value and drugs that do not exist are of no value,” said Norman Augustine, chair of the National Academies of Sciences, Engineering and Medicine’s... Read More »

Read More →

The nation’s most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to change. “Drugs that are not affordable are of little value and drugs that do not exist are of no value,” said Norman Augustine, chair of the National Academies of Sciences, Engineering and Medicine’s… Read More »

[...]

Read More

Excitement Builds Around Gene Therapy Cures For Hemophilia

How enthralled are scientists by the prospects for gene therapy in hemophilia, the deadly disease of uncontrolled bleeding? Ask the usually staid New England Journal of Medicine, which just ran this headline: “A Cure for Hemophilia [is] within Reach.” It would be one of medicine’s holy grails — and they are the talk of the... Read More »

Read More →

How enthralled are scientists by the prospects for gene therapy in hemophilia, the deadly disease of uncontrolled bleeding? Ask the usually staid New England Journal of Medicine, which just ran this headline: “A Cure for Hemophilia [is] within Reach.” It would be one of medicine’s holy grails — and they are the talk of the… Read More »

[...]

Read More

Pfizer Breast Cancer Drug Superior to Chemotherapy in Late Stage Study

(Reuters) – Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday. The drug, talazoparib, a once daily pill that... Read More »

Read More →

(Reuters) – Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday. The drug, talazoparib, a once daily pill that… Read More »

[...]

Read More

FDA approves first biosimilar for the treatment of certain breast and stomach cancers

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or... Read More »

Read More →

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or… Read More »

[...]

Read More

FDA approves first-of-a-kind test for cancer gene profiling

U.S. regulators have approved a first-of-a-kind test that looks for mutations in hundreds of cancer genes at once, giving a more complete picture of what’s driving a patient’s tumor and aiding efforts to match treatments to those flaws. The U.S. Food and Drug Administration approved Foundation Medicine’s test for patients with advanced or widely spread... Read More »

Read More →

U.S. regulators have approved a first-of-a-kind test that looks for mutations in hundreds of cancer genes at once, giving a more complete picture of what’s driving a patient’s tumor and aiding efforts to match treatments to those flaws. The U.S. Food and Drug Administration approved Foundation Medicine’s test for patients with advanced or widely spread… Read More »

[...]

Read More

Don’t Delay Hip Fracture Surgery. Here’s Why

Seniors with a fractured hip need surgery as soon as possible or they could suffer life-threatening complications, a new Canadian study concludes. Having surgery within 24 hours decreases the risk of hip fracture-related death. It also lowers odds of problems such as pneumonia, heart attack and blocked arteries, the researchers found. “We found that there... Read More »

Read More →

Seniors with a fractured hip need surgery as soon as possible or they could suffer life-threatening complications, a new Canadian study concludes. Having surgery within 24 hours decreases the risk of hip fracture-related death. It also lowers odds of problems such as pneumonia, heart attack and blocked arteries, the researchers found. “We found that there… Read More »

[...]

Read More

The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens’ power after cataract surgery so that the patient will have better vision when not using glasses. Cataracts are a common eye condition where… Read More »

[...]

Read More

Calorie counts on menus are going to be mandatory in 2018

It’s finally happening. After nearly a decade of delays, the Food and Drug Administration is expected to implement an Obama-era policy that will require restaurants and other food outlets with 20 or more locations to post calorie counts beginning May 2018. Any big chain — from grocery stores to movie theaters, amusement parks to vending... Read More »

Read More →

It’s finally happening. After nearly a decade of delays, the Food and Drug Administration is expected to implement an Obama-era policy that will require restaurants and other food outlets with 20 or more locations to post calorie counts beginning May 2018. Any big chain — from grocery stores to movie theaters, amusement parks to vending… Read More »

[...]

Read More

Gene Therapy Creates Replacement Skin to Save a Dying Boy

Doctors in Europe used gene therapy to grow sheets of healthy skin that saved the life of a boy with a genetic disease that had destroyed most of his skin, the team reported on Wednesday in the journal Nature. This was not the first use of the treatment, which adds gene therapy to a technique... Read More »

Read More →

Doctors in Europe used gene therapy to grow sheets of healthy skin that saved the life of a boy with a genetic disease that had destroyed most of his skin, the team reported on Wednesday in the journal Nature. This was not the first use of the treatment, which adds gene therapy to a technique… Read More »

[...]

Read More

Page 1 of 22

Categories
Archives